AIDS Vaccine Advocacy Coalition
AIDS Vaccine Advocacy Coalition reported $10.0 million in revenue and $13.8 million in expenses for calendar year 2024. Of every $100 it spent, $81.21 went to program services, $18.53 to management and general costs and $0.26 to fundraising. Its largest source of revenue was contributions and grants: 99.3% of the total. Government grants made up 54.5%. The highest compensation it reported for one person was $448,315 (EXECUTIVE DIRECTOR). 22 people received more than $100,000 in reportable compensation. Revenue fell 17% between 2019 and 2024. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $14MFor context, the median across 3,614 covered human services charities: $88.27 programs, $11.52 management, $0.21 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $10MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 81.2% | 87.2% |
| Management & general Part IX 25(C) ÷ 25(A) | 18.5% | 11.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.3% | 0.2% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.02 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 99.3% | 20.6% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 54.5% | 2.4% |
| Program service revenue share Part VIII 2g ÷ 12 | 0.0% | 70.8% |
| Highest reported compensation Part VII-A, columns D–F | $448,315 | $274,992 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 3.25% | 1.18% |
| People paid over $100,000 Part VII, line 2 | 22 | 6 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 2.6 | 6.9 |
| Independent voting board members Part VI 1a–1b | 15 of 16 | 100.0% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseResearch engagement and preparedness: research preparedness is designed to shape the r&d environment through advocacy for investment, political support, and good participatory practice. Avac tracks and translates both community advocacy and complex science to make the science accessible and position community priorities at the center of global health. Avac improved trial design and conduct by bringing together researchers, trial site staff, civil society, policymakers, trial participants, and communities to center perspectives of affected communities in research. Avac developed materials and…
Product introduction and access: the product introduction program is designed to identify and anticipate needs and gaps and provide targeted tools, support and platforms to expand access to HIV/AIDS prevention. The program focuses on: successful scale-up and introduction in three priority countries from the outset; develop adaptable and scalable tools to support other countries; support the development of marketable products in the HIV prevention and sexual and reproductive health research pipeline; and create a flexible mechanism to assist product developers, funders and country programs to…
Global movement building: global movement building cultivates the next generation of advocates via the avac fellows and advocacy navigator programs. Advocates are equipped with the skills, opportunities and access to drive change in HIV prevention and global health equity by amplifying community voices and influencing policy and research. Alumni of these programs are leading, internationally recognized civil society advocates. They have gone on to found civil society organizations, influence the HIV prevention research pipeline, and shape conversations and objectives in the field. Avac also…
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| EXECUTIVE DIRECTOR Director/trustee, officer, 50.00 hrs/week | $400,812 | $0 | $47,503 | $448,315 |
| CHIEF OPERATING OFFICER Officer, 40.00 hrs/week | $253,516 | $0 | $64,419 | $317,935 |
| CHIEF FINANCIAL OFFICER Officer, 40.00 hrs/week | $237,388 | $0 | $65,924 | $303,312 |
| DIRECTOR, RESEARCH ENGAGEMENT Highest compensated employee, 40.00 hrs/week | $188,580 | $0 | $64,004 | $252,584 |
| DIRECTOR, POLICY ADVOCACY Highest compensated employee, 40.00 hrs/week | $175,549 | $0 | $63,584 | $239,133 |
| DIRECTOR, PARTNERSHIPS Highest compensated employee, 40.00 hrs/week | $191,190 | $0 | $47,348 | $238,538 |
| DIRECTOR, FINANCE Highest compensated employee, 40.00 hrs/week | $169,312 | $0 | $60,370 | $229,682 |
| DIRECTOR, COMMUNICATIONS Highest compensated employee, 40.00 hrs/week | $172,382 | $0 | $26,666 | $199,048 |
22 people received more than $100,000 in reportable compensation from AIDS Vaccine Advocacy Coalition (Part VII, line 2). Compensation of current officers, directors and key employees totaled $1.1M (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b16 · 15 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 537
Largest outside contractors
2024 · Form 990, Part VII, Section B · businesses only| ALLEGIANCE FUNDRAISING LLC Website design services | $128,901 |
Individuals listed as contractors are left out. 4 contractors were paid more than $100,000 in all.
Private foundation grants it received
2 private foundations reported grants to AIDS Vaccine Advocacy Coalition totaling $6.3M on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from AIDS Vaccine Advocacy Coalition's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for AIDS Vaccine Advocacy Coalition, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 AIDS Vaccine Advocacy Coalition spent in 2024, $81.21 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Vista on 5th CorpNew York, NY · revenue $10M · programs 56.0% · 2024
- Young Mens Christian Association of Central VirginiaLynchburg, VA · revenue $10M · programs 97.6% · FY2025
- Apple Patch CommunityCrestwood, KY · revenue $10M · programs 87.0% · FY2025
- Crisis Control MinistryWinstonsalem, NC · revenue $10M · programs 89.7% · FY2025
- Shaohannahs HopeFranklin, TN · revenue $10M · programs 72.2% · FY2025
All human services charities · Largest charities in New York
Questions people ask
How much of AIDS Vaccine Advocacy Coalition's spending goes to programs?
In calendar year 2024, AIDS Vaccine Advocacy Coalition reported that 81.2% of its $13.8 million in expenses went to program services, 18.5% to management and general and 0.3% to fundraising (Form 990, Part IX).
How much does AIDS Vaccine Advocacy Coalition pay its top executive?
The largest total compensation AIDS Vaccine Advocacy Coalition reported for one person in calendar year 2024 was $448,315, for the role of EXECUTIVE DIRECTOR (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does AIDS Vaccine Advocacy Coalition get its money?
Of $10.0 million in revenue in calendar year 2024, 99.3% came from contributions and grants (including 54.5% from government grants) and 0.0% from program service revenue (Form 990, Part VIII).
Is AIDS Vaccine Advocacy Coalition a registered charity?
The IRS lists EIN 94-3240841 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202522839349301047 · read the filing · XML
- 2023: Form 990 for calendar year 2023, object 202413109349301411 · read the filing
- 2022: Form 990 for calendar year 2022, object 202343149349300814 · read the filing
- 2021: Form 990 for calendar year 2021, object 202213159349305201 · read the filing
- 2020: Form 990 for calendar year 2020, object 202123199349301447 · read the filing
- 2019: Form 990 for calendar year 2019, object 202033189349300538 · read the filing
All filings for EIN 94-3240841: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.